The global polymerase chain reaction (PCR) market size is expected to surpass US$ 8.1 Bn by 2030 and is estimated to expand at a CAGR of 6.4% from 2021 to 2030.
The global polymerase chain reaction (PCR) market size is expected to surpass US$ 8.1 Bn by 2030 and is estimated to expand at a CAGR of 6.4% from 2021 to 2030.
Manufacturers in the PCR market are increasing the production for nose swab PCR tests for accurate and reliable testing for the COVID-19 virus. However, it has been found that the accuracy of RT-PCR results rely heavily on sample collection timing, type, storage, handling, and processing. The tests diagnose active infection only and cannot detect whether an individual was infected previously. A false negative result is possible if the sample is not properly obtained or if an individual is tested too early after the exposure to the virus or too late in their infection. Nevertheless, companies in the PCR market should boost output capacities for PCR tests due to the high prevalence of existing and potential infectious diseases.
Get the sample copy of report@ https://qyresearchmedical.com/sample/112075
PCR Gains Prominence in Ever-expanding Pharmaceutical and Biotechnology Industries
The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as in microbiological quality control. Additionally, the approach is used in genetic engineering. Genetic engineering is one of the primary drivers for the expansion of the global PCR market. PCR is being used to discover genes associated with specific phenotypes, such as genetic illnesses. The regular testing of raw materials and finished products for microbial contamination is a critical practice in pharmaceutical and biotechnology industries.
| Report Scope | Details |
| Market Size By 2030 | USD 8.1 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.4% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
PCR is frequently used in critical processes for clinical laboratory research pertaining to various purposes, including biological research and criminal legal sciences. Polymerase chain reaction is a technique widely used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively. Such findings are contributing toward growth of the PCR market.
Ask here for more details@ https://qyresearchmedical.com/submit-inquiry/112075
Unprecedented Demand for RT-PCR Tests for COVID-19 Detection Creating Revenue Streams
The polymerase chain reaction test for COVID-19 is a molecular test that analyzes the upper respiratory specimen, looking for genetic material (ribonucleic acid or RNA) of SARS-CoV-2, the virus that causes COVID-19. Scientists are using the PCR technology to amplify small amounts of RNA from specimens into deoxyribonucleic acid (DNA), which is replicated until SARS-CoV-2 is detectable, if present. The PCR test has been emerging as the gold standard test for diagnosing COVID-19 since authorized for use in February 2020. Its accurate, convenient, and reliable outcome is being preferred by labs and research institutes.
High Prevalence of Infectious Diseases in Asia Pacific to Expand Gobal Market
Molecular diagnosis has transformed modern diagnostic science, and polymerase chain reaction has emerged as the method of choice for the early & reliable detection of diseases. The expansion of top manufacturers of PCR products in Asia Pacific through network strengthening and new product launches in developing countries are key factors expected to drive the PCR market in the region during the forecast period.
Increase in incidence of cancer and infectious diseases has driven the demand for the use of polymerase chain reaction technique in clinical diagnosis of these diseases across Asia Pacific. The Korea Central Cancer Registry reported in 2016 that South Korea had 217,057 cancer cases in 2014. Such findings are fueling the growth of the Asia Pacific PCR market.
PCR Emerges as Alternative to Traditional Sputum Smear Microscopy Approach
Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations. According to the World Health Organization (WHO), an estimated 10 million individuals were infected with tuberculosis globally in 2019. Thus, the PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach. China, India, and Indonesia were among the countries having a higher prevalence of the disease.
According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals worldwide. The rise in incidence of various infectious diseases is driving the demand for diagnostic products, which is expected to boost the growth of the PCR market.
Manufacturers Develop Comprehensive Product Portfolio for PCR Products
The introduction of advanced reagents specific to the type of test is expected to propel the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers & probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions.
Manufacturers in the PCR market are increasing production for standard PCR systems, RT PCR systems, and digital PCR systems. The revenue share of digital PCR systems is expected to grow at a rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification & multiplexing, and speed of analysis.
Polymerase Chain Reaction (PCR) Market: Overview
Polymerase chain reaction (PCR) is a technique used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively
It is used for genetic testing and research, including the examination of archaic DNA samples and the identification of irresistible specialists
Rise in R&D Expenditure: Key Driver
Increase in R&D expenditure, developments in pharmacogenomics, trend of self-diagnosis of diseases as a preventive measure, and emergence of the digital PCR technology highly benefiting cancer diagnosis are factors projected to boost the growth of the global PCR market during the forecast period
Moreover, rise in research & development activities in advanced molecular biology, genetic engineering, and forensic science are anticipated to propel the global PCR market during the forecast period
Rise in Prevalence of Tuberculosis and Other Infectious Diseases: Major Driver
Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations
According to the World Health Organization (WHO), an estimated ten million individuals were infected with tuberculosis globally in 2019. Additionally, this PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach.
China, India, and Indonesia were among the countries having a higher prevalence of the disease
According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals worldwide. Increase in incidence of various infectious diseases drives demand for diagnostic products, which is expected to boost the growth of the global market.
Pharmaceutical & Biotechnology Segment to Dominate Global Polymerase Chain Reaction (PCR) Market
The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as microbiological quality control
Additionally, the approach is used in genetic engineering. Genetic engineering is the primary driver of the global polymerase chain reaction (PCR) market.
It is used to discover genes associated with specific phenotypes, such as genetic illnesses
Regular testing of raw materials and finished products for microbial contamination is a critical practice in the pharmaceutical and biotechnology industries
In the pharmaceutical industry, sophisticated analytical procedures such as polymerase chain reaction (PCR) have been frequently used for quality control analysis
North America to Dominate Global Polymerase Chain Reaction (PCR) Market
Increase in incidence of various types of cancer and metabolic diseases that demand advanced diagnosis and therapies are the major factors driving the market in North America
The advent of automated PCR instruments and higher purchasing power and affordability fuel the growth of the PCR market in developed countries in Europe such as the U.K., France, Italy, and Germany. Moreover, less stringent regulatory approval processes compared to the U.S. fuel the PCR market in Europe.
The market in Asia Pacific is projected to grow at a rapid pace during the forecast period, owing to improving health care infrastructure, rise in private and public investment in life science research, and technological advancements in countries such as China and India
Major Players
Key players operating in the global polymerase chain reaction (PCR) market include
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
- Becton
- Dickinson and Company
- Abbott
- Siemens Healthcare GmbH (Siemens AG)
- bioMérieux SA
- Danaher Corporation
- Agilent Technologies
Each of these players has been profiled in the polymerase chain reaction (PCR) market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments
Key Questions Answered in Global Polymerase Chain Reaction Market Report
- What will be the revenue generated in the polymerase chain reactions market across all geographies during the forecast period?
- What are key trends in the global polymerase chain reactions market?
- What are major drivers, restraints, and opportunities in the market?
- Which region is set to expand at a high CAGR during the forecast period?
- Which segment of the global polymerase chain reactions will generate the maximum revenue globally by 2028?
- Which segment will expand at the maximum CAGR during the forecast period?
Polymerase Chain Reaction Market – Segmentation
Product Type
- Instruments
- Standard PCR
- RT PCR
- Digital PCR
- Reagents
- Consumables
End-user
- Pharmaceutical & Biotechnology Industries
- Clinical Diagnostics Labs & Hospitals
- Academic & Research Organizations
- Others
Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112075/
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/